Potential of a lytic bacteriophage to disrupt Acinetobacter baumannii biofilms in vitro

Future Microbiology

Volumn 11, Issue 11, 2016, Pages 1383-1393

  Liu, Yannan ^a,b   Mi, Zhiqiang ^c   Niu, Wenkai ^b   An, Xiaoping ^c   Yuan, Xin ^b   Liu, Huiying ^b   Wang, Yong ^b   Feng, Yuzhong ^b   Huang, Yong ^c   Zhang, Xianglilan ^c   Zhang, Zhiyi ^c   Fan, Hang ^c   Peng, Fan ^d   Li, Puyuan ^b   Tong, Yigang ^c   Bai, Changqing ^b  

^a HEBEI NORTH UNIVERSITY   (China)

^b Beijing 307 Hospital   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^d First Hospital of Changsha   (China)

Author keywords

Acinetobacter baumannii; bacteriophage; biofilm; disinfection; resistance

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIBIOTIC AGENT; DISINFECTANT AGENT; LUCIFERIN; OSMIUM TETRAOXIDE; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIOPHAGE; BIOFILM; CONTROLLED STUDY; DISINFECTION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; ACINETOBACTER INFECTIONS; CHINA; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; PHAGE THERAPY; PHYSIOLOGY; PROCEDURES; SPUTUM; STAINING; VIROLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADENOSINE TRIPHOSPHATE; ANTI-BACTERIAL AGENTS; BACTERIOPHAGES; BIOFILMS; CHINA; DISINFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; PHAGE THERAPY; SPUTUM; STAINING AND LABELING;

EID: 84994121839     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb-2016-0104     Document Type: Article

References (32)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21(3), 538-582 (2008).
2. Behnia M, Logan SC, Fallen L, Catalano P. Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis. BMC Res. Notes 7, 232 (2014).
3. Antunes LC, Visca P, Towner KJ. Acinetobacter baumannii: evolution of a global pathogen. Pathog. Dis. 71(3), 292-301 (2014).
4. Lee K, Yong D, Jeong SH, Chong Y. Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med. J. 52(6), 879-891 (2011).
5. Zarrilli R, Pournaras S, Giannouli M, Tsakris A. Global evolution of multidrugresistant Acinetobacter baumannii clonal lineages. Int. J. Antimicrob. Agents 41(1), 11-19 (2013).
6. Badave GK, Kulkarni D. Biofilm producing multidrug resistant Acinetobacter baumannii: an emerging challenge. J. Clin. Diagn. Res. 9(1), DC08-DC10 (2015).
7. Espinal P, Marti S, Vila J. Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J. Hosp. Infect. 80(1), 56-60 (2012).
8. Verbeken G, De Vos D, Vaneechoutte M, Merabishvili M, Zizi M, Pirnay JP. European regulatory conundrum of phage therapy. Future Microbiol. 2(5), 485-491 (2007).
9. Cao Z, Zhang J, Niu YD et al. Isolation and characterization of a phiKMV-like bacteriophage and its therapeutic effect on mink hemorrhagic pneumonia. PLoS ONE 10(1), e0116571 (2015).
10. Rose T, Verbeken G, Vos DD et al. Experimental phage therapy of burn wound infection: difficult first steps. Int. J. Burns Trauma 4(2), 66-73 (2014).
11. Citorik RJ, Mimee M, Lu TK. Sequencespecific antimicrobials using efficiently delivered RNA-guided nucleases. Nat. Biotechnol. 32(11), 1141-1145 (2014).
12. Sambanthamoorthy K, Feng X, Patel R, Patel S, Paranavitana C. Antimicrobial and antibiofilm potential of biosurfactants isolated from lactobacilli against multi-drug-resistant pathogens. BMC Microbiol. 14, 197 (2014).
13. Tennert C, Feldmann K, Haamann E et al. Effect of photodynamic therapy (PDT) on Enterococcus faecalis biofilm in experimental primary and secondary endodontic infections. BMC Oral Health 14, 132 (2014).
14. Reffuveille F, De La Fuente-Nunez C, Mansour S, Hancock RE. A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms. Antimicrob. Agents Chemother. 58(9), 5363-5371 (2014).
15. Thawal ND, Yele AB, Sahu PK, Chopade BA. Effect of a novel podophage AB7-IBB2 on Acinetobacter baumannii biofilm. Curr. Microbiol. 65(1), 66-72 (2012).
16. Lood R, Winer BY, Pelzek AJ et al. Novel phage lysin capable of killing the multidrugresistant Gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model. Antimicrob. Agents Chemother. 59(4), 1983-1991 (2015).
17. Chopra S, Harjai K, Chhibber S. Potential of sequential treatment with minocycline and S. aureus specific phage lysin in eradication of MRSA biofilms: an in vitro study. Appl. Microbiol. Biotechnol. 99(7), 3201-3210 (2015).
18. Hughes KA, Sutherland IW, Jones MV. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144(11), 3039-3047 (1998).
19. Chhibber S, Nag D, Bansal S. Inhibiting biofilm formation by Klebsiella pneumoniae B5055 using an iron antagonizing molecule and a bacteriophage. BMC Microbiol. 13(1), 1 (2013).
20. Peng F, Mi Z, Huang Y et al. Characterization, sequencing and comparative genomic analysis of vB-AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates. BMC Microbiol. 14, 181 (2014).
21. Wang Y, Mi Z, Niu W et al. Intranasal treatment with bacteriophage rescues mice from Acinetobacter baumannii-mediated pneumonia. Future Microbiol. 11, 631-641 (2016).
22. Hoopes JT, Stark CJ, Kim HA, Sussman DJ, Donovan DM, Nelson DC. Use of a bacteriophage lysin, PlyC, as an enzyme disinfectant against Streptococcus equi. Appl. Environ. Microbiol. 75(5), 1388-1394 (2009).
23. GraphPad Software. www.graphpad.com.
24. Orsinger-Jacobsen SJ, Patel SS, Vellozzi EM et al. Use of a stainless steel washer platform to study Acinetobacter baumannii adhesion and biofilm formation on abiotic surfaces. Microbiology 159(Pt 12), 2594-2604 (2013).
25. Longo F, Vuotto C, Donelli G. Biofilm formation in Acinetobacter baumannii. New Microbiol. 37(2), 119-127 (2014).
26. Sillankorva SM, Oliveira H, Azeredo J. Bacteriophages and their role in food safety. Int. J. Microbiol. 2012, 863945 (2012).
27. Yele AB, Thawal ND, Sahu PK, Chopade BA. Novel lytic bacteriophage AB7-IBB1 of Acinetobacter baumannii: isolation, characterization and its effect on biofilm. Arch. Virol. 157(8), 1441-1450 (2012).
28. Thandar M, Lood R, Winer BY, Deutsch DR, Euler CW, Fischetti VA. Novel engineered peptides of a phage lysin as effective antimicrobials against multidrugresistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 60(5), 2671-2679 (2016).
29. Labrie SJ, Samson JE, Moineau S. Bacteriophage resistance mechanisms. Nat. Rev. Microbiol. 8(5), 317-327 (2010).
30. O'flynn G, Ross RP, Fitzgerald GF, Coffey A. Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7. Appl. Environ. Microbiol. 70(6), 3417-3424 (2004).
31. Pereira C, Moreirinha C, Lewicka M et al. Bacteriophages with potential to inactivate Salmonella Typhimurium: use of single phage suspensions and phage cocktails. Virus Res. 220 179-192 (2016)
32. Sharma M. Lytic bacteriophages: potential interventions against enteric bacterial pathogens on produce. Bacteriophage 3(2), e25518 (2013).